<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00584220</url>
  </required_header>
  <id_info>
    <org_study_id>CR-0714B</org_study_id>
    <nct_id>NCT00584220</nct_id>
  </id_info>
  <brief_title>Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear</brief_title>
  <official_title>Evaluation of Fit and Visual Acuity of the Investigational Toric Lens in Two Phases: Part B: A Dispensing Cross-over Comparison to SofLens66 Toric</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Foresight Regulatory Strategies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the relative performance of a new toric soft
      contact lens against a toric contact lens currently available in market, specifically with
      regards to the comfort and vision after two weeks of use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dispensing, single-masked (subject-masked), randomized, 2-visit controlled study of two-weeks
      duration.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective Reported Vision</measure>
    <time_frame>1 week</time_frame>
    <description>A weighted combined score of one week and two week data calculated from individual vision-related questions asked on a 1-5 scale, 1 = most negative response to 5 = most positive, was used to derive vision outcomes. The analysis shows the outcome for both senofilcon A and alphafilcon A. If score &gt;0 then greater vision, if &lt;0 then lesser vision.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subject Reported Lens Comfort.</measure>
    <time_frame>1 week</time_frame>
    <description>A weighted combined score of one week and two week data calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the estimates for senofilcon A and alphafilcon A, respectively. Interpretation is &gt;0 indicates comfortable and &lt;0 indicates uncomfortable.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>senofilcon A toric / alphafilcon A toric</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>senofilcon A toric contact lenses worn daily during the first period, then alphafilcon A toric contact lenses worn daily during the second period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alphafilcon A toric / senofilcon A toric</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>alphafilcon A toric contact lenses worn daily during the first period, then senofilcon A toric contact lenses worn daily during the second period</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>senofilcon A toric</intervention_name>
    <description>contact lens</description>
    <arm_group_label>senofilcon A toric / alphafilcon A toric</arm_group_label>
    <arm_group_label>alphafilcon A toric / senofilcon A toric</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>alphafilcon A toric</intervention_name>
    <description>contact lens</description>
    <arm_group_label>senofilcon A toric / alphafilcon A toric</arm_group_label>
    <arm_group_label>alphafilcon A toric / senofilcon A toric</arm_group_label>
    <other_name>SofLens66 Toric</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Prior to being considered eligible to participate in this study,
        subjects MUST

          1. be at least 18 and less than or equal to 39 years of age and have a need for vision
             correction in BOTH eyes (monovision or uniocular fitting is NOT allowed).

          2. be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry)
             and have Asian Eye anatomy.

          3. have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact
             lenses for at least 4-weeks prior to enrollment in the study.

          4. be able and willing to adhere to the instructions set forth in the protocol.

          5. agree to wear their contact lenses in both eyes on a daily wear schedule for at least
             8 hours per day every day during the study.

          6. have a distance spherical component between -1.00 D and -5.50 D with cylinder in the
             range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20
             ° of the horizontal in both eyes

          7. have a best corrected manifest refraction visual acuity of at least 20/25 or better in
             each eye.

          8. be in good general health, based on his/her knowledge.

          9. read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF
             INFORMED CONSENT.

        Exclusion Criteria:

          1. The subject is a rigid gas permeable (RGP) or daily disposable soft lens wearer.

          2. The presence of clinically significant (grade 3 or 4) anterior segment abnormalities;
             inflammations such as iritis; or any infection of the eye, lids, or associated
             structures.

          3. The presence of ocular or systemic disease or need for medication which might
             interfere with contact lens wear or which would cause the lenses to be removed more
             than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc).

          4. Slit lamp findings that would contraindicate contact lens wear such as:

               -  Pathological dry eye or associated findings

               -  Pterygium or corneal scars within the visual axis

               -  Neovascularization &gt;1mm in from the limbus

               -  History of giant papillary conjunctivitis (GPC) worse than Grade 2

               -  Anterior uveitis or iritis (past or present)

               -  Seborrhoeic eczema, seborrhoeic conjunctivitis

          5. A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal
             infections.

          6. A known history of corneal hypoesthesia (reduced corneal sensitivity.)

          7. Aphakia, keratoconus or a highly irregular cornea.

          8. Current pregnancy or lactation (to the best of the subject's knowledge).

          9. Active participation in another clinical study at any time during this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason Chin, O.D.</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>James Fujimoto, O.D.</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>Weslie Hamada, O.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arthur T. Kobayashi, O.D., Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dennis Kuwuabara, O.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eye Care Associates of Hawaii</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Nakano, O.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mark E. Nakano Optometric Corp.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ikuko Sugimoto, O.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unaffilliated</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kevin Rosin, O.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Drs. Farkas, Kassalow, Resnick &amp; Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer Kao, O.D.</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2007</study_first_submitted>
  <study_first_submitted_qc>December 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2008</study_first_posted>
  <results_first_submitted>August 21, 2009</results_first_submitted>
  <results_first_submitted_qc>January 28, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 19, 2010</results_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <responsible_party>
    <name_title>Kurt Moody, OD, FAAO./ Manager, Clinical Research</name_title>
    <organization>Vistakon</organization>
  </responsible_party>
  <keyword>Astigmatism</keyword>
  <keyword>vision</keyword>
  <keyword>comfort</keyword>
  <keyword>satisfaction</keyword>
  <keyword>contact lenses</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of those 96 enrolled subjects in the study, 7 did not meet the study eligibility criteria and 1 did not receive the study lenses. One enrolled subject was discontinued from the study leaving n=87 who completed the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Senofilcon A / Alphafilcon A</title>
          <description>senofilcon A toric silicone hydrogel contact lenses worn first, then alphafilcon A toric hydrogel contact lenses worn second</description>
        </group>
        <group group_id="P2">
          <title>Alphafilcon A / Senofilcon A</title>
          <description>alphafilcon A toric hydrogel contact lenses worn first, then senofilcon A toric silicone hydrogel contact lenses worn second</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline summary was conducted on enrolled subjects who completed the study.</population>
      <group_list>
        <group group_id="B1">
          <title>All Subjects</title>
          <description>Subjects who enrolled and completed the study.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="87"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.0" spread="5.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Subjective Reported Vision</title>
        <description>A weighted combined score of one week and two week data calculated from individual vision-related questions asked on a 1-5 scale, 1 = most negative response to 5 = most positive, was used to derive vision outcomes. The analysis shows the outcome for both senofilcon A and alphafilcon A. If score &gt;0 then greater vision, if &lt;0 then lesser vision.</description>
        <time_frame>1 week</time_frame>
        <population>Analysis includes only participants who completed the study per protocol and had no missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
            <description>contact lenses</description>
          </group>
          <group group_id="O2">
            <title>Alphafilcon A Toric</title>
            <description>contact lenses</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Reported Vision</title>
          <description>A weighted combined score of one week and two week data calculated from individual vision-related questions asked on a 1-5 scale, 1 = most negative response to 5 = most positive, was used to derive vision outcomes. The analysis shows the outcome for both senofilcon A and alphafilcon A. If score &gt;0 then greater vision, if &lt;0 then lesser vision.</description>
          <population>Analysis includes only participants who completed the study per protocol and had no missing data.</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="87"/>
                <count group_id="O2" value="87"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="0.795"/>
                    <measurement group_id="O2" value="-0.17" spread="0.788"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subject Reported Lens Comfort.</title>
        <description>A weighted combined score of one week and two week data calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the estimates for senofilcon A and alphafilcon A, respectively. Interpretation is &gt;0 indicates comfortable and &lt;0 indicates uncomfortable.</description>
        <time_frame>1 week</time_frame>
        <population>Analysis includes only participants who completed the study per protocol and had no missing data.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
            <description>contact lenses</description>
          </group>
          <group group_id="O2">
            <title>Alphafilcon A Toric</title>
            <description>contact lenses</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Reported Lens Comfort.</title>
          <description>A weighted combined score of one week and two week data calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the estimates for senofilcon A and alphafilcon A, respectively. Interpretation is &gt;0 indicates comfortable and &lt;0 indicates uncomfortable.</description>
          <population>Analysis includes only participants who completed the study per protocol and had no missing data.</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="87"/>
                <count group_id="O2" value="87"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" spread="0.730"/>
                    <measurement group_id="O2" value="-0.38" spread="0.723"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Senofilcon A</title>
          <description>senofilcon A toric silicone hydrogel contact lenses worn</description>
        </group>
        <group group_id="E2">
          <title>Alphafilcon A</title>
          <description>alphafilcon A toric hydrogel contact lenses worn</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="96"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="96"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kurt Moody, OD, FAAO</name_or_title>
      <organization>Vistakon</organization>
      <phone>904-443-3088</phone>
      <email>kmoody1@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

